You are here: Industry Insights > acquisition

News List

Takeda clinches $62B deal to drugmaker Shire biospectrumasia
May 09, 2018
The final deal is approximately 46 percent cash and 54 percent stock, leaving Shire shareholders owning around half of the combined group.
First-quarter acquisition activity lifts hopes for a big year EvaluatePharma
April 24, 2018
In the annals of biopharma M&A the first quarter of 2018 will go down as another strong start to the year, with $34bn in deals achieved without the benefit of a single mega-merger.
Bliss GVS Pharma buys stake in Eco-rich Cosmetic India expressbpd
April 23, 2018
The transaction was completed through its 70 per cent subsidiary, Kremoint Pharma
Luye strengthens presence in Singapore with NHC acquisition biospectrumasia
April 11, 2018
Based in the heart of Singapore’s premier medical hub, Novena Heart Centre is one of the largest and fastest growing multi-disciplinary cardiology group practices in Singapore with plans to set up more clinics
ImmunoPrecise acquires ModiQuest for €7M biospectrumasia
April 10, 2018
As a result of the acquisition of ModiQuest, ImmunoPrecise is now an innovative, integrated antibody solutions company focused on the next generation of technology behind therapeutic antibody discovery.
Roche completes Flatiron Health acquisition biospectrumasia
April 10, 2018
Flatiron partners with more than 265 community cancer clinics, six major academic research centres, and 14 therapeutic oncology companies.
Novartis to buy AveXis for $8.7B biospectrumasia
April 10, 2018
Novartis expects the acquisition to "strongly contribute" to core operating income and earnings per share.
LivaNova completes TandemLife acquisition biospectrumasia
April 08, 2018
Under the terms of the agreement, LivaNova paid $200 million to TandemLife at closing with an additional $50 million to be paid based on specified regulatory milestones.
Ferring acquires Rebiotix Inc. biospectrumasia
April 08, 2018
The most advanced investigational microbiome treatment from Rebiotix is RBX2660, a non-antibiotic treatment currently in Phase 3 development for the prevention of recurrent CDI
Agilent Tech to acquire Lasergen for $105M biospectrumasia
April 04, 2018
Lasergen and Agilent have been collaborating on building a next-generation sequencing workflow for clinical applications.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page